Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection.
Calò
Lorenzo A
LA
Pagnin
Elisa
E
Sartori
Michelangelo
M
Semplicini
Andrea
A
Pessina
Achille C
AC
D001477:Bartter Syndrome / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000517:prevention & control*; D007008:Hypokalemia / Q000188:drug therapy* / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D054460:rho-Associated Kinases
D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases